APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,904,000 | +203.1% | 101,085 | +100.6% | 0.04% | +169.2% |
| Q2 2022 | $2,278,000 | +132.2% | 50,380 | +161.1% | 0.01% | +225.0% |
| Q1 2022 | $981,000 | +190.2% | 19,298 | +261.1% | 0.00% | +300.0% |
| Q2 2021 | $338,000 | -57.6% | 5,344 | -79.8% | 0.00% | -90.9% |
| Q3 2020 | $797,000 | +7.1% | 26,422 | +15.9% | 0.01% | -8.3% |
| Q2 2020 | $744,000 | +177.6% | 22,790 | +128.1% | 0.01% | +71.4% |
| Q1 2020 | $268,000 | -57.0% | 9,991 | -50.9% | 0.01% | +75.0% |
| Q4 2019 | $623,000 | -41.1% | 20,359 | -53.6% | 0.00% | -55.6% |
| Q3 2019 | $1,057,000 | -34.8% | 43,897 | -31.4% | 0.01% | -43.8% |
| Q2 2019 | $1,622,000 | +80.4% | 64,000 | +38.8% | 0.02% | +60.0% |
| Q1 2019 | $899,000 | +58.8% | 46,111 | +7.5% | 0.01% | +42.9% |
| Q4 2018 | $566,000 | +50.9% | 42,904 | +103.3% | 0.01% | +75.0% |
| Q3 2018 | $375,000 | – | 21,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |